Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Haloperidol/quetiapine

Neuroleptic malignant syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Alioglu Karayilan F, et al. Neuroleptic malignant syndrome with haloperidol and quetiapine treatment in a schizophrenia patient: A case report and 1 year follow up. European Psychiatry 66 (Suppl. 1): S1005, Mar 2023. Available from: URL: http://doi.org/10.1192/j.eurpsy.2023.2133 [abstract] Alioglu Karayilan F, et al. Neuroleptic malignant syndrome with haloperidol and quetiapine treatment in a schizophrenia patient: A case report and 1 year follow up. European Psychiatry 66 (Suppl. 1): S1005, Mar 2023. Available from: URL: http://​doi.​org/​10.​1192/​j.​eurpsy.​2023.​2133 [abstract]
Metadaten
Titel
Haloperidol/quetiapine
Neuroleptic malignant syndrome: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-46533-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics